Literature DB >> 28588782

Rapidly progressing large-cell neuroendocrine carcinoma arising from the uterine corpus: A case report and review of the literature.

Aya Kobayashi1, Tamaki Yahata1, Sakiko Nanjo1, Mika Mizoguchi1, Madoka Yamamoto1, Yasushi Mabuchi1, Shigetaka Yagi1, Sawako Minami1, Kazuhiko Ino1.   

Abstract

Large-cell neuroendocrine carcinoma (LCNEC) is a high-grade neuroendocrine tumor. LCNECs arising from the genital organs are highly malignant and rare, with <20 cases of LCNEC developing from the uterine endometrium reported to date. We herein present the case of a patient with LCNEC of the endometrium. The patient was a 52-year-old woman, who exhibited lower abdominal pain and rapid uterine enlargement during outpatient treatment for uterine myoma. The endometrial biopsy suggested a diagnosis of poorly differentiated carcinoma or carcinosarcoma. Based on magnetic resonance imaging and positron emission tomography/computed tomography, endometrial stromal sarcoma was suspected. The serum lactate dehydrogenase level was abnormally high. Due to the suspicion of stage IIIC malignant tumor of the uterine corpus, surgery was performed. The pathological diagnosis was stage IIIC2 LCNEC of the endometrium. Recurrence occurred in the vaginal stump, and concurrent chemoradiotherapy (CCRT) was initiated 1 month after the surgery. The residual lesions markedly shrank, but metastasis to the upper abdominal region and cervix subsequently developed. CCRT was attempted, but the associated adverse effects were severe and was switched to palliative treatment. The patient eventually succumbed to the disease 309 days after surgery.

Entities:  

Keywords:  concurrent chemoradiotherapy; endometrium; large-cell neuroendocrine carcinoma

Year:  2017        PMID: 28588782      PMCID: PMC5451872          DOI: 10.3892/mco.2017.1229

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  19 in total

1.  Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.

Authors:  C B Gilks; R H Young; D J Gersell; P B Clement
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

2.  Octreotide induced remission of a refractory small cell carcinoma of the endometrium.

Authors:  C. F. Verschraegen; C. Matei; E. Loyer; A. Malpica; C. Tornos; A. P. Kudelka; J. J. Kavanagh
Journal:  Int J Gynecol Cancer       Date:  1999-01       Impact factor: 3.437

3.  Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA.

Authors:  Tadashi Terada
Journal:  Pathol Res Pract       Date:  2010-02-26       Impact factor: 3.250

4.  [A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11+CDDP chemotherapy after non-curative surgery].

Authors:  Hirotoshi Tanimoto; Aki Hamasaki; Yumiko Akimoto; Hiroshi Honda; Yuko Takao; Kei Okamoto; Mitsue Teramoto; Hideki Teramoto; Mayumi Kaneko; Takafumi Oshita
Journal:  Gan To Kagaku Ryoho       Date:  2012-09

5.  Rare large cell neuroendocrine tumor of the endometrium: A case report and review of the literature.

Authors:  My-Linh T Nguyen; Liying Han; Anjoinette M Minors; Stuart Bentley-Hibbert; Tana S Pradhan; Tara L Pua; Sean S Tedjarati
Journal:  Int J Surg Case Rep       Date:  2013-05-03

Review 6.  Large cell neuroendocrine cervical carcinoma: a report of two cases and review of the literature.

Authors:  T C Krivak; J W McBroom; M J Sundborg; B Crothers; M F Parker
Journal:  Gynecol Oncol       Date:  2001-07       Impact factor: 5.482

7.  Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.

Authors:  Nicholas J Mulvany; David G Allen
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

8.  Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis.

Authors:  Jorge Albores-Saavedra; Braulio Martinez-Benitez; Eduardo Luevano
Journal:  Int J Gynecol Pathol       Date:  2008-07       Impact factor: 2.762

Review 9.  Large cell neuroendocrine carcinoma of the uterine corpus metastatic to brain and lung: case report and review of the literature.

Authors:  Y Erhan; Y Dikmen; M S Yucebilgin; O Zekioglu; L Mgoyi; M C Terek
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

10.  Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus.

Authors:  Shohreh Shahabi; Ilenia Pellicciotta; June Hou; Sarah Graceffa; Gloria S Huang; Robert N Samuelson; Gary L Goldberg
Journal:  Rare Tumors       Date:  2011-10-11
View more
  6 in total

1.  Dedifferentiated Endometrioid Carcinomas with Neuroendocrine Differentiation: A Clinicopathological and Immunohistochemical Study of Three Cases.

Authors:  Feng Zhou; Xiaofei Zhang; Hao Chen; Wenxin Zheng
Journal:  Cancer Manag Res       Date:  2020-11-13       Impact factor: 3.989

2.  Mixed large and small cell neuroendocrine carcinoma of the endometrium with serous carcinoma: A case report and literature review.

Authors:  Ruijiao Hu; Jiyong Jiang; Guangyao Song; Chenggong Zhu; Liyan Chen; Chenhui Wang; Xiuying Wang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Anterior mediastinal large cell neuroendocrine carcinoma with elevated AFP: A case report and review.

Authors:  Justin Komisarof; Haoming Qiu; Moises J Velez; Deborah Mulford
Journal:  Mol Clin Oncol       Date:  2020-12-22

4.  Primary Neuroendocrine Tumors of the Endometrium: Management and Outcomes.

Authors:  Jingjing Zhang; Li Pang
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

5.  Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium.

Authors:  Liesel Elisabeth Hardy; Zia Chaudry; King Wan; Chloe Ayres
Journal:  BMJ Case Rep       Date:  2020-09-02

Review 6.  Gynecologic large cell neuroendocrine carcinoma: A review.

Authors:  Grant Burkeen; Aman Chauhan; Rohitashva Agrawal; Riva Raiker; Jill Kolesar; Lowell Anthony; B Mark Evers; Susanne Arnold
Journal:  Rare Tumors       Date:  2020-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.